Metformin is associated with reduced COVID-19 severity in patients with prediabetes

Chan, L. E., Casiraghi, E., Laraway, B., Coleman, B., Blau, H., Zaman, A., Harris, N. L., Wilkins, K., Antony, B., Gargano, M., Valentini, G., Sahner, D., Haendel, M., Robinson, P. N., Bramante, C., Reese, J. Metformin is associated with reduced COVID-19 severity in patients with prediabetes. Diabetes Research and Clinical Practice. 2022.